Inhibitor Therapeutics INTI
OTC INTI
$0.09 -0.02 (-18.18%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Net Shares Issued and Repurchased (2014 - 2016)

Updated

Analysis

Inhibitor Therapeutics (INTI) Net Shares Issued and Repurchased (2014 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -9.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Inhibitor Therapeutics 15.64 Mn 8.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 4.54 Mn
Dec 31, 2014 550,000.00
Sep 30, 2014 550,000.00
API Access

Inhibitor Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=INTI&period=max&api_key=YOUR_API_KEY